Xiaoling Li
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
-
- Cancer-related molecular mechanisms research 12
-
- Chromatin Remodeling and Cancer 13
- Protein Degradation and Inhibitors 12
- RNA modifications and cancer 12
- Cancer-related gene regulation 11
- Genomics and Chromatin Dynamics 10
- Co-authors
- Guiyuan Li (50 shared papers)Wei Xiong (26 shared papers)Zhaoyang Zeng (24 shared papers)Yong Li (8 shared papers)Yongzhen Mo (6 shared papers)Can Jie Guo (7 shared papers)Lianxiang Luo (12 shared papers)Fang Xiong (7 shared papers)
- Journals
- Journal of Biological Chemistry (6 papers)Molecular Cancer (6 papers)Physical review. D (4 papers)Cancer Letters (4 papers)Journal of Cancer (4 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Xiaoling Li
227 papers receiving 8.0k citations
Xiaoling Li's Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 1.7k
- Immunology 1.3k
- Oncology 1.5k
- Molecular Biology 3.6k
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Xiaoling Li
This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).
Fields of papers citing papers by Xiaoling Li
This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neoantigen vaccine: an emerging tumor immunotherapy Hit paper breakdown → | 2019 | 583 |
| 2 | The role of microenvironment in tumor angiogenesis Hit paper breakdown → | 2020 | 582 |
| 3 | 2017 | 315 | |
| 4 | Single‐cell RNA sequencing in cancer research Hit paper breakdown → | 2021 | 280 |
| 5 | 2019 | 209 | |
| 6 | 2021 | 178 | |
| 7 | 2003 | 151 | |
| 8 | 2018 | 150 | |
| 9 | Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01) Hit paper breakdown → | 2022 | 136 |
| 10 | 2006 | 134 | |
| 11 | 2017 | 123 | |
| 12 | 2020 | 117 | |
| 13 | Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant Hit paper breakdown → | 2024 | 115 |
| 14 | 2022 | 114 | |
| 15 | 2008 | 109 | |
| 16 | 2021 | 108 | |
| 17 | 2021 | 107 | |
| 18 | 2017 | 101 | |
| 19 | 2020 | 100 | |
| 20 | 2022 | 100 |
About Xiaoling Li
Xiaoling Li is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 239 papers that have together received 8.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Chromatin Remodeling and Cancer (13 papers), Protein Degradation and Inhibitors (12 papers), Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (12 papers), Ferroptosis and cancer prognosis (11 papers), Cancer-related gene regulation (11 papers) and Genomics and Chromatin Dynamics (10 papers). The work is most often cited by research in Cancer Research (1.7k citations), Immunology (1.3k citations), Oncology (1.5k citations), Molecular Biology (3.6k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Xiaoling Li has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Yong Li, Yongzhen Mo, Can Jie Guo, Lianxiang Luo, Fang Xiong, Qianjin Liao and Xiayu Li. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cancer, Physical review. D, Cancer Letters and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.